A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN)

Overview of attention for article published in Supportive Care in Cancer, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 4 X users
patent: 2 patents

guideline: 2 clinical guideline sources

Readers on

mendeley: 132 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 3,641 followers.

Clinical trials needed to assess vitamin B12 in reducing the onset & severity of CIPN @schloss_janet https://t.co/wf8x419cYQ

RT @B12unme2: They do their best t'save doomed oral B12 but only Pt to attain any actual remission of CIPN had B12 injection too. https://…

RT @B12unme2: RCT shows B12d patients taking oral B vits may only feel analgesic relief as opposed to actual protection of nerves https://t…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.